Clinical profile and survival of patients undergoing surgery for non-small cell lung cancer: Impact of positron emission tomography adoption

C. Clément-Duchêne, I. Lemonnier, F. Guillemin, J. M. Vignaud, G. Gauchotte, S. Lacomme, G. Grosdidier, J. Siat, Y. Martinet (Vandoeuvre-Lès-Nancy, Nancy, France)

Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Session: Diagnosis, imaging and surgery for thoracic tumours
Session type: Thematic Poster Session
Number: 2771
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Clément-Duchêne, I. Lemonnier, F. Guillemin, J. M. Vignaud, G. Gauchotte, S. Lacomme, G. Grosdidier, J. Siat, Y. Martinet (Vandoeuvre-Lès-Nancy, Nancy, France). Clinical profile and survival of patients undergoing surgery for non-small cell lung cancer: Impact of positron emission tomography adoption. Eur Respir J 2014; 44: Suppl. 58, 2771

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014


Impact of PET scan on staging and management of lung cancer patients in Indian scenario
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016


The utility of fluorodeoxyglucose positron emission tomographyin the evaluation of carcinoid tumors presenting as pulmonary nodules. Experience in our hospital
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014


Algorithm of preoperative N-staging of non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013


Computed tomographic screening for lung cancer: individualising the benefit of the screening
Source: Eur Respir J 2007; 30: 843-847
Year: 2007



Safety and efficacy of erlotinib in patients with squamous cell lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014

Association with emphysema on computed tomography and lung cancer in smokers
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014


Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Prognostic value of preoperative C-reactive protein in resectable non-small cell lung cancer - 5-years prospective study
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Primary lung cancer treated using radiofrequency ablation: Two year outcome data
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014

Improving survival for NSCLC patients in the national lung cancer audit
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015


EBUS-TBNA for nodal restaging and relapse in lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

Outcomes of radical treatment of early stage non-small cell lung cancer
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015


Surgical treatment outcomes on early-stages of non-small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015